Homocysteine status in former top-level male athletes: Possible effect of physical activity and physical fitness

Scandinavian Journal of Medicine and Science in Sports

Volumn 18, Issue 3, 2008, Pages 360-366

  Unt, E ^a   Zilmer, K ^a   Magi A ^b   Kullisaar, T ^a   Kairane, C ^a   Zilmer, M ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Ex athletes; Exercise; Glutathione; Homocysteine; Maximal oxygen consumption

Indexed keywords

GLUTATHIONE REDUCTASE; HOMOCYSTEINE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; EXERCISE; FITNESS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PHYSIOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SPORT;

ADULT; ANTHROPOMETRY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; EXERCISE; GLUTATHIONE REDUCTASE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OXYGEN CONSUMPTION; PHYSICAL FITNESS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SPORTS;

EID: 44349164657     PISSN: 09057188     EISSN: 16000838     Source Type: Journal    
DOI: 10.1111/j.1600-0838.2007.00674.x     Document Type: Article

References (33)

1. Ainsworth BE, Haskell WL, Leon AS, Jacobs Jr. DR, Montoye HJ, Sallis JF, Paffenbarger Jr. RS Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993 : 25 : 71 80.
2. Andreotti F, Burzotta F, Manzoli A, Robinson K. Homocysteine and risk of cardiovascular disease. J Thromb Thrombolysis 2000 : 9 : 13 21.
3. Bolander-Gouaille C, Bottiglieri T. Homocysteine related vitamins and neuropsychiatric disorders. France : Springer-Verlag, 2003.
4. Booth FW, Gordon SE, Carlson CJ, Hamilton MT. Waging war on modern chronic disease: primary prevention through exercise biology. J Appl Physiol 2000 : 88 : 774 787.
5. D.A.CH.-Liga Homocysteine. Consensus Paper on the Rational Clinical Use of Homocysteine, Folic Acid, and B-Vitamins in Cardiovascular and Thrombotic Diseases-Guidelines and Recommendations-German, Austrian, and Swiss Homocysteine Society, May 2003.
6. El-Khairy L, Uueland PM, Nygård O, Refsum H, Vollset SE. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999 : 70 : 1016 1024.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 : 285 : 2486 2497.
8. Fogelholm M, Kaprio J, Sarna S. Healthy lifestyles of former Finnish world class athletes. Med Sci Sports Exerc 1994 : 26 : 224 229.
9. Fruchart J-C, Nierman MC, Stroes ESG, Kastelein JJP, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004 : 109 (1) : III15 III19.
10. Gibala MJ. Regulation of skeletal muscle amino acid metabolism during exercise. Int J Sport Nutr Exerc Metab 2001 : 11 : 87 108.
11. Hellgren M, Melander A, Ostgren CJ, Rastam L, Lindblad U. Inverse association between plasma homocysteine, sulphonylurea exposure and physical activity: a community-based sample of type 2 diabetes patients in the Skaraborg hypertension and diabetes project. Diabetes Obes Metab 2005 : 7 : 421 429.
12. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002 : 288 : 2015 2022.
13. Joubert LM, Manore MM. Exercise, nutrition, and homocysteine. Int J Sport Nutr Exerc Metab 2006 : 16 : 341 361.
14. Kaul S, Zadeh AA, Shah PK. Homocysteine hypothesis for atherothrombotic cardiovascular disease. Not validated. J Am Coll Cardiol 2006 : 48 : 914 923.
15. Kujala UM, Kaprio J, Taimela S, Sarna S. Prevalence of diabetes, hypertension, and ishemic disease in former elite athletes. Metab Clin Experim 1994 : 43 : 1255 1260.
16. Kullisaar T, Zilmer M, Mikelsaar M, Vihalemm T, Annuk H, Kairane C, Kilk A. Two antioxidative lactobacilli strains as promising probiotics. Int J Food Microbiol 2002 : 72 : 215 224.
17. König D, Bissé E, Deibert P, Müller H-M, Wieland H, Berg A. Influence of training volume and acute physical exercise on the homocysteine levels in endurance-trained men: interactions with plasma folate and vitamin B12. Ann Nutr Metab 2003 : 47 : 114 118.
18. Kuo HK, Yen CJ, Bean JF. Levels of homocysteine are inversely associated with cardiovascular fitness in women, but not in men: data from the National Health and Nutrition Examination Survey, 1999-2002. J Intern Med 2005 : 258 : 328 335.
19. Leong T, Fitzgerald A, McGorrian C, Graham I. Homocysteine, apolipoprotein B/AI ratio and the metabolic syndrome are predictors of cardiovascular risk using the SCORE system. Irish J Med Sci 2005 : 174 (Suppl.) : 58 59.
20. Mansoor MA, Kristensen O, Hervig T, Drablos PA, Stakkestad JA, Woie L, Hetland O, Osland A. Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and nonsmokers. Clin Chem 1997 : 43 : 2192 2194.
21. Muda P, Kampus P, Zilmer M, Zilmer K, Kairane C, Ristmäe T, Fischer K, Teesalu R. Homocysteine and red blood cell glutathione as indices for middle-aged untreated essential hypertension patients. J Hypertension 2003 : 21 : 2329 2333.
22. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997 : 337 : 230 236.
23. Nygård O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M, Kvale G. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995 : 274 : 1526 1533.
24. O'Callaghan P, Meleady R, Fitzgerald T, Graham I. The European COMAC group. Smoking and plasma homocysteine. Eur Heart J 2002 : 23 : 1580 1586.
25. Paffenbarger Jr. RS, Hyde RT, Wing AL, Steinmetz CH. A natural history of athleticism and cardiovascular health. JAMA 1984 : 252 : 491 495.
26. Pihl E, Jürimäe T, Kaasik T. Coronary heart disease risk factors in middle-aged former top-level athletes. Scand J Med Sci Sports 1998 : 8 : 229 235.
27. Pihl E, Zilmer K, Kullisaar T, Kairane C, Pulges A, Zilmer M. High-sensitive C-reactive protein level and oxidative stress-related status in former athletes in relation to traditional cardiovascular risk factors. Atherosclerosis 2003 : 171 : 321 326.
28. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 2001 : 103 : 2717 2723.
29. Rinder MR, Spina RJ, Ehsani AA. Enhanced endothelium-dependent vasodilation in older endurance-trained men. J Appl Physiol 2000 : 88 : 761 766.
30. Saltin B, Grimby G. Physiological analysis of middle-aged and old former athletes. Comparison with still active athletes of the same age. Circulation 1968 : 38 : 1104 1115.
31. Sen CK. Oxidants and antioxidants in exercise. J Appl Physiol 1995 : 79 : 675 686.
32. Splaver A, Lamas GA, Hennekens CH. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 2004 : 148 : 34 40.
33. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence and causality from a meta-analysis. JAMA 2002 : 325 : 1202 1226.